Probiotics can help heal ravaged coral reefs
SCTLD first emerged in Florida in 2014. In the 11 years since, it has rapidly spread throughout the Caribbean. This mysterious ailment has been confirmed in at least 20 other countries and territories.
Other coral pathogens typically target specific species. SCTLD infects more than 30 different species of stony corals, including pillar corals and brain corals. The disease causes the soft tissue in the corals to slough off, leaving behind white patches of exposed skeleton. The disease can devastate an entire coral colony in only a few weeks to months.
The exact cause of SCTLD is still unknown, but it appears to be linked to some kind of harmful bacteria. Currently, the most common treatment for SCTLD is using a paste that contains the antibiotic amoxicillin on diseased corals. However, antibiotics are not a silver bullet. This amoxicillin balm can temporarily halt SCTLD's spread, but it needs to be frequently reapplied to the lesions on the corals. This takes time and resources, while increasing the likelihood that the microbes causing SCTLD might develop resistance to amoxicillin and related antibiotics.
'Antibiotics do not stop future outbreaks,' Valerie Paul, a study co-author and the head scientist at the Smithsonian Marine Station at Fort Pierce, Florida, said in a statement. 'The disease can quickly come back, even on the same coral colonies that have been treated.'
Paul and her colleagues have spent over six years investigating whether beneficial microorganisms (aka probiotics) could be a longer lasting alternative to combat this pathogen.
Just like humans, corals are host to communities known as microbiomes that are bustling with all different types of bacteria. Some of these miniscule organisms produce antioxidants and vitamins that can help keep their coral hosts healthy.
[ Related: Caribbean coral is getting sick and dying. A probiotic could help. ]
First, the team looked at the microbiomes of corals that are impervious to SCTLD to try and harvest probiotics from these disease-resistant species. In theory, these could be used to strengthen the microbiomes of susceptible corals.
They tested over 200 strains of bacteria from disease-resistant corals and published a study in 2023 about the probiotic Pseudoalteromonas sp. McH1-7 (or McH1-7 for short). Taken from the great star coral (Montastraea cavernosa), this probiotic produces several antibacterial compounds. Having such a stacked antibacterial toolbox made McH1-7 an ideal candidate to combat a pathogen like SCTLD.
They initially tested McH1-7 on live pieces of M. cavernosa and found that the probiotic reliably prevented the spread of SCTLD in the lab. After these successful lab tests, the wild ocean called next.
The team conducted several field tests on a shallow reef near Fort Lauderdale, focusing on 40 M. cavernosa colonies that showed signs of SCTLD. Some of the corals in these colonies received a paste containing the probiotic McH1-7 that was applied directly to the disease lesions. They treated the other corals with a solution of seawater containing McH1-7 and covered them using weighted plastic bags. The probiotics were administered inside the bag in order to cover the entire coral colony.
'This created a little mini-aquarium that kept the probiotics around each coral colony,' Paul said.
For two and a half years, they monitored the colonies, taking multiple rounds of tissue and mucus samples to see how the corals' microbiomes were changing over time. They found that the McH1-7 probiotic successfully slowed the spread of SCTLD when it was delivered to the entire colony using the bag and solution method. According to the samples, the probiotic was effective without dominating the corals' natural microbes.
While using this probiotic appears to be an effective treatment for SCTLD among the reefs of northern Florida, additional work is needed to see how it could work in other regions. Similar tests on reefs in the Florida Keys have been conducted, with mixed preliminary results, likely due to regional differences in SCTLD.
The team believes that probiotics still could become a crucial tool for combatting SCTLD across the Caribbean, especially as scientists fine tune how to administer them. Importantly, these beneficial bacteria support what corals already do naturally.
'Corals are naturally rich with bacteria and it's not surprising that the bacterial composition is important for their health,' Paul said. 'We're trying to figure out which bacteria can make these vibrant microbiomes even stronger.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
3 days ago
- Associated Press
7-HOPE Alliance Responds to Misinformation in Dr. Robert Redfields Recent Op-Ed on 7-Hydroxymitragynine (7-OH) in The Hill
Alliance Scientific Advisor Pens Letter Correcting Key Scientific Inaccuracies From Media Op/Ed LOS ANGELES, CA - July 1, 2025 ( NEWMEDIAWIRE ) - 7-HOPE Alliance ('7-HOPE'), a nonprofit public education and advocacy group dedicated to responsible access to 7-hydroxymitragynine (7-OH), today issued the following letter from Scientific Advisor Dr. Michele Ross in response to former CDC Director Dr. Robert Redfield's recent opinion article published in The Hill. Dr. Redfield's op-ed unfoundedly equated 7-OH with synthetic opioids, alleged it poses 'legal morphine-level' risks, and called for immediate enforcement action by the FDA and HHS. While his concern for public safety is genuine, it is also clear that Dr. Redfield was misinformed, likely by commercial actors with a vested interest in removing 7-OH from the market. The following letter, written by Dr. Michele Ross and originally submitted as a Letter to the Editor with no response from the publication, directly addresses the scientific, regulatory, and policy inaccuracies in the op-ed. 'As a neuroscientist who has spent nearly two decades researching addiction and working with chronic pain patients, I share Dr. Redfield's concern about emerging drug trends. But his recent warning about 7-hydroxymitragynine, or 7-OH, paints an inaccurate and potentially harmful picture of a compound that many Americans are using to stay off far more dangerous substances. Most concerning is the claim that 7-OH is a 'synthetic opioid.' That label is scientifically inaccurate. 7-OH is a naturally occurring compound found in the kratom plant and is also produced in significant quantities inside the human body after consuming kratom leaf. When product manufacturers produce 7-OH outside the body, they are not creating a novel or lab-invented drug. They are mimicking the body's own metabolic process using heat and oxygen, a method no different from how other botanical extracts are refined or stabilized for dietary supplements. To call this synthetic is not only misleading, it falsely associates 7-OH with fentanyl-class opioids and risks misinforming both lawmakers and the public. Published studies show that 7-OH acts as a partial agonist at opioid receptors, unlike fentanyl, a full opioid agonist. 7-OH has a ceiling effect on euphoria which makes it more similar to the opioid use disorder treatment buprenorphine than fentanyl. Unlike traditional opioids, it does not activate the beta-arrestin 2 pathway strongly associated with respiration depression, overdose, and death. Multiple rodent studies have attempted to find a lethal dose for 7-OH and failed – that alone separates it from the synthetic opioids devastating our communities. Dr. Redfield suggests that 7-OH poses an 'unregulated pharmaceutical threat,' but this ignores the rigorous safety practices already in place among responsible manufacturers. 7-HOPE supports strict milligram-based serving limits and accurate labeling standards, not unlike those already applied to THC and CBD in regulated markets. Dr. Redfield also references an FDA clinical trial on natural kratom leaf to suggest 7-OH products represent a 'bait and switch.' But this misrepresents the research. That study evaluated natural kratom leaf in experienced users and found no serious adverse effects. What it also revealed is that kratom and its active metabolites, including 7-OH, show low abuse potential and may offer therapeutic benefits. Rather than contradict the utility of 7-OH, this research supports continued exploration of its properties, especially as a harm reduction tool. Further, the suggestion that federal agencies must act immediately to issue 'import alerts' and 'classify 7-OH as an unapproved drug' is premature and reckless. Research on 7-OH is ongoing, and early findings show promise. HHS has already rejected scheduling kratom and its components once, citing the risk of immediate harm to users if access is cut off. That decision still holds today. We do not ban nicotine or even alcohol because they carry risks. We regulate them. The same approach should be applied here. What Dr. Redfield's op-ed leaves out entirely is the human impact of a ban on 7-OH. Millions rely on 7-OH to manage pain, reduce alcohol use, or avoid relapse from other deadly synthetics. These are not hypothetical users. I have heard from consumers, veterans, and parents who credit this compound with helping them get their lives back. When people are desperate to avoid fentanyl or oxycodone but have few options, removing one of the few effective, low-toxicity alternatives is not harm reduction, it's cruelty. Yes, 7-OH should be researched further and regulated, but as we know from repeated history,bans or broad mischaracterizations will not make people safer. They will push individuals back toward illicit markets and high-risk alternatives. If we are serious about harm reduction, we must let science, not stigma, lead the way. Respectfully Submitted, Dr. Michele Ross, PhD, MBA Scientific Advisor, 7-HOPE Alliance Author of Kratom is Medicine 7-HOPE urges lawmakers, regulators, and the media to engage with the science and lived experiences of the people who use 7-OH safely every day. We remain committed to supporting ongoing research, promoting responsible regulation, and ensuring this compound remains accessible to those who rely on it for pain relief, recovery, and stability. For more information or to get involved, visit About 7-HOPE Alliance 7-HOPE Alliance (7-Hydroxy Outreach for Public Education) is a nonprofit organization (501(c)(3) pending) dedicated to advancing public education, user support, and policy advocacy around 7-hydroxymitragynine (7-OH), a naturally occurring alkaloid in the kratom plant. Through a foundation of science, storytelling, and community, 7-HOPE empowers individuals, healthcare professionals, and policymakers with accurate, balanced information on 7-OH and its role in harm reduction, natural wellness, and safe, legal access to alternatives. The organization's mission centers on four pillars: science, education, advocacy, and user support. By confronting misinformation, promoting responsible use, and providing uplifting real-life testimonials, 7-HOPE aims to ensure 7-OH remains available to the many individuals who find it to be a safe and effective alternative to dangerous painkillers and illegal drugs. For more information or to get involved, visit Media Contact [email protected] View the original release on
Yahoo
25-06-2025
- Yahoo
Smallest Alien World Ever Seen Spotted by JWST in Stunning First
JWST has made another breakthrough. Around a newly formed star just 111 light-years away, the powerful space telescope has officially discovered its first exoplanet. It's called TWA-7b, and it's the smallest world that humanity has ever directly imaged. TWA-7b is a cold gas giant with about a third of the mass of Jupiter, orbiting its red dwarf host star at a staggering distance – 52 times farther than Earth orbits the Sun. In our Solar System, that distance would place TWA-7b out in the Kuiper Belt, far beyond the orbit of Pluto. Related: Stunning Direct Images of Alien Worlds Are Detailed Enough to Reveal Clouds The planet isn't the only remarkable thing here. So detailed are the observations that a team led by astronomer Anne-Marie Lagrange of the Paris Observatory in France has been able to confirm predictions about how planets form, and their interactions with their environment. The discovery, the researchers say, demonstrates the promise of JWST, not just for studying exoplanets indirectly, but for finding and studying them directly, beyond the range other instruments can reach. "The present results show that the JWST Mid-Infrared Instrument (MIRI) has opened up a new window in the study of sub-Jupiter-mass planets using direct imaging," they write in their paper. "Indeed, TWA-7b (about 100 times the mass of Earth) is at least 10 times lighter than the exoplanets directly imaged so far, and planets as light as 25 to 30 Earth masses could have been detected if present." To date, nearly 6,000 exoplanets have been confirmed, out there in the Milky Way galaxy. That's pretty exciting, considering how hard they are to discern. They're very small, very dim, and very far away; the vast majority of them have only ever been measured indirectly, based on changes their presence wreaks on the light of their stars. We've only actually directly seen around 80 exoplanets. The star TWA-7 is perfectly positioned in space for attempting to directly image an exoplanet. It's around 6.4 million years old, which is the star equivalent of a toddler – so young that it's still surrounded by a leftover disk of the material that fed the baby star as it grew. It's from these disks that planets are born. Material clumps together as it orbits the star, gradually building up until there's enough mass to constitute a world. This process creates gaps in the disk where the new planet carves out a space and creates rings, 'shepherding' the material on either side of the gap, a lot like the shepherd moons of the rings of Saturn. Well, so we think. As Lagrange and her colleagues note, "no planet responsible for these features has been detected yet." TWA-7 is oriented in such a way that its pole is pointing at Earth. That means that astronomers can see the full disk of material around it, divided into three distinct rings. Lagrange and her colleagues pointed JWST at this disk, looking to see if they could identify an exoplanet in one of the gaps between the rings, creating a cavity for itself in the material around TWA-7. "We unambiguously detected a source 1.5 arcseconds from the star, which is best interpreted as a cold, sub-Jupiter-mass planet," they write. Their analysis suggests that this world is about the same mass as Saturn. It's a marvelous discovery, one that dramatically extends the lower mass range for directly detectable exoplanets. It's also possibly only scratching the surface; the researchers believe that JWST is capable of observing worlds that are much less massive than TWA-7b. The telescope is often used to analyze exoplanet atmospheres based on the way starlight changes when it passes through. Direct imaging is an entirely different way of studying exoplanets that can reveal details that are difficult to obtain in any other way. The researchers conclude that TWA-7b is an exciting prospect for further study. "TWA-7b is very well suited for further detailed dynamical modelling of disk-planet interactions," they observe. "As it is angularly well resolved from the star, TWA-7b is suited for direct spectroscopic investigations, providing the opportunity to study the interior and the atmosphere of a non-irradiated sub-Jupiter-mass, cold (about 320 K) exoplanet, and start comparative studies with our much older and cooler Solar System giants." The research has been published in Nature. Record-Sized Comet Seen Belching Jets From Surface as It Heads Our Way Behold! World's Largest Camera Snaps Millions of Galaxies in First Pics 2032 'City-Killer' Impact Threatens Earth's Satellites, Study Finds
Boston Globe
18-06-2025
- Boston Globe
Sally Ride became the first American woman in space 42 years ago today. Here's how weather played a role then and now.
For the launch to be successful, the weather had to be near perfect, and the east coast of Central Florida was basking in amazing conditions that morning. Liftoff commenced without delay with temperatures in the low 70s and near-still wind. This NASA file photo dated June 1983 shows America's first woman astronaut Sally Ride, as she communicates with ground controllers from the flight deck during the six-day space mission of the Challenger. Ride, the first US woman to fly in space, died on July 23, 2012 after a 17-month battle with pancreatic cancer. She was 61. - But bad weather in Florida upon return to Earth June 24, 1983, forced Challenger to land three time zones away at Edwards Air Force Base, Calif., in the Mojave desert, where still conditions were certain, especially for a powerless glider that depended on a stable atmosphere to land comfortably. The base also provided very wide runways for a smooth Challenger landing. Sally Ride and STS-7 returns safely in California after bad weather in Florida changed the landing location. NASA Advertisement NASA has strict parameters in place when it comes to weather to 'greenlight' a launch — most of which are obvious. Wind speed and direction need to be light and steady. High winds of 30 miles per hour or more will usually scrap flight plans for the day, and any sudden changes in wind direction may cause issues as the rocket moves vertically through the atmosphere. (Back when Sally Ride was breaking barriers in the Space Shuttle program, launches were delayed or canceled when wind speeds were as low as 22 miles per hour.) Advertisement High visibility with little to no cloud cover is also necessary. Any instability in the atmosphere, albeit minor, can cause lightning when a rocket burning copious amounts of fuel at extreme temperatures blasts through. Apollo 12 was struck by lightning twice during liftoff on Nov. 14, 1969, because of its heat production. Essentially, the rocket's exhaust system acted as a lightning rod and sparked lightning with already-lifting air from a nearby cold front. Temperatures and humidity both play critical roles in NASA rocket launches, as everything from the structural integrity and rocket performance can be impacted by weather conditions. Fuel, insulation, wiring, and other components can expand, contract, or break down if weather conditions aren't ideal. Many will remember the Challenger's last trip on Jan. 28, 1986, when air temperatures were 36 degrees, approximately 15 degrees colder than any other shuttle launch, causing the O-ring seal to become brittle and ultimately fail, leading to a catastrophic explosion. All Weather continues to play a critical role in NASA's strict 'launch commit criteria,' and if anything is near or outside the safe range, the launch is delayed or scrubbed for another day. Here's a look at an example weather checklist when considering safe conditions to launch. An example of the weather checklist utilized to proceed or delay a rocket launch at Cape Canaveral. NASA Ken Mahan can be reached at
